Navigation Links
LCT and Otsuka of Japan Share Common DIABECELL(R) Vision
Date:4/12/2011

han 30 June 2011. Assuming shareholder approval of the conversion of the Note is obtained, the Note will automatically convert into 6,000,000 ordinary shares in LCT on the next business day after the date on which shareholder approval is obtained. If shareholder approval for the conversion of Note into Ordinary Shares is not obtained, the Note is repayable together with interest at the rate of 7.5% per annum on 31 December 2011.

About Living Cell Technologies - www.lctglobal.com

Living Cell Technologies (LCT) is developing cell-based products to treat life threatening human diseases. The Company owns a biocertified pig herd that it uses as a source of cells for treating diabetes and neurological disorders. For patients with Type 1 diabetes, the Company transplants microencapsulated islet cells so that near-normal blood glucose levels may be achieved without the need for administration of insulin or at significantly reduced levels. The Company entered clinical trials for its diabetes product in 2007. For the treatment of Parkinson's disease and other neurological disorders, the company transplants microencapsulated choroid plexus cells that deliver beneficial proteins and neurotrophic factors to the brain. LCT's technology enables healthy living cells to be injected into patients to replace or repair damaged tissue without requiring the use of immunosuppressive drugs to prevent rejection. LCT also offers medical-grade porcine-derived products for the repair and replacement of damaged tissues, as well as for research and other purposes.

About Otsuka Pharmaceutical Factory - www.otsukakj.jp/en/

Otsuka Pharmaceutical Factory, Inc., the first company in the Otsuka Group, was established by Busaburo Otsuka in 1921. Originally, the company manufactured and distributed industrial and pharmaceutical chemicals. It began manufacturing intravenous solutions
'/>"/>

SOURCE LCT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
2. Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration
3. BioWa Announces Second Japanese License of POTELLIGENT(R) Technology to Otsuka Pharmaceutical
4. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
5. Aribex and IDENS Donate 15 Victim I.D. Kits for Japan
6. Volcano Announces the Introduction of the PrimeWire PRESTIGE® Pressure Guide Wire in Japan
7. MSA Increases Production of Air-Purifying Respirators to Help Meet Increased Demand from Japan
8. PromiseCare Pharmacy Donates to Soles4Souls® Japanese Relief Efforts
9. Heyltex Corporation Working With United States and Japan to Add Production of Radiological Antidotes
10. Medco Foundation Donates $100,000 to Red Cross for Japanese Earthquake and Pacific Tsunami Relief
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... NEW YORK , May 16, 2013 Developers ... and sends patient reminders have emerged as grand prize winners ... diabetes innovation challenge funded by Boehringer Ingelheim and organized by ... Josh Stein , John Langhauser ... AdhereTech from the United States ...
(Date:5/16/2013)... YORK , May 16, 2013 /PRNewswire/ ... company that develops innovative targeted payload immunotherapeutics ... the official program of TAT: Target Alpha ... presentation devoted to Actinium Pharmaceuticals, clinical programs.  ... Myeloid Leukemia with Bismuth-213 and Actinium-225" has ...
(Date:5/16/2013)... 16, 2013  Lakewood-Amedex Inc., a leading developer ... recent series of in vitro studies ... of antimicrobials, named bisphosphocins, function through a completely ... resulting in rapid direct bacterial killing.  These studies ... be superior to ciprofloxacin.  The studies revealed the ...
Breaking Medicine Technology:Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 2Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 2Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 4
... Mylan Inc. (Nasdaq: MYL ) today announced ... from the U.S. Food and Drug Administration (FDA) for its ... 8.5 mg, 17 mg, 25.5 mg and 34 mg. Mylan ... ANDA containing a Paragraph IV certification for Nisoldipine ER Tablets ...
... Inc. (Amex: AEN ), a developer of innovative ... it has executed an agreement for the sale of approximately ... share to two new institutional investors in a registered direct ... also receive warrants to purchase approximately 1.42 million shares of ...
Cached Medicine Technology:Adeona to Raise $4 Million in Registered Direct Offering 2Adeona to Raise $4 Million in Registered Direct Offering 3
(Date:5/17/2013)... May 17 (HealthDay News) -- There are apps that turn ... a GPS system, and now there,s an app that may ... attack. The app, which was designed by engineers and ... severe heart attacks, called STEMIs, before patients get to the ... but it has undergone field testing. In a STEMI ...
(Date:5/17/2013)... a higher burden of disease and lower life expectancy ... of men are notably absent from the strategies of ... this week,s Lancet . , The article reinterprets ... which shows that all of the top ten causes ... risk factors driving rates of ill-health around the world, ...
(Date:5/17/2013)... Florida Hospital Tampa is ... and implement programs providing education, support and development to ... special emphasis on health-related initiatives and those events which ... partnership started in January of 2012 with the formal ... until March 19, 2015. The cooperative educational program entitled, ...
(Date:5/17/2013)... 17 (HealthDay News) -- Teen bullies are more likely ... finds. UT Dallas researchers analyzed several decades of ... All of them had similar working-class backgrounds and most ... were in their mid-50s. Nearly half of the ... years engaged in some form of criminal activity -- ...
(Date:5/17/2013)... transplants to treat a common type of liver cancer ... according to new research. The Italian study, published ... found that the AIDS-causing virus doesn,t affect survival rates ... this particular type of liver cancer, called hepatocellular carcinoma ... more aggressive in people with HIV and it is ...
Breaking Medicine News(10 mins):Health News:Heart Attack? Doctors Soon May Have an App for That 2Health News:Heart Attack? Doctors Soon May Have an App for That 3Health News:Global health policy fails to address burden of disease on men 2Health News:Florida Hospital Tampa Partners with Hillsborough County Public Schools Offering Health Educational Programs and Support to Students 2Health News:Florida Hospital Tampa Partners with Hillsborough County Public Schools Offering Health Educational Programs and Support to Students 3Health News:HIV No Barrier to Getting Liver Transplant, Study Finds 2
... twice before buying their next pair of high-heels or pumps, ... Hebrew SeniorLife in a new study of older adults and ... women wear, specifically high-heels, pumps and sandals, may cause future ... who reported hind-foot pain regularly wore these types of shoes ...
... individuals from the field of pharmaceutical research are expected to ... - 12, 2009 at the Los Angeles Convention Center in ... have the opportunity to present new research, methods and technologies ... only is the meeting the premiere international event for the ...
... ... healthcare professionals, today announced that it has acquired the assets of Medical Concepts Staffing ... , ... (PRWEB) September 28, 2009 -- Temps Inc., ( www.tempsinc.net ) a national provider of ...
... cons of cancer screen not understood, research shows, , MONDAY, ... told the pros and cons of PSA tests, two new ... they can,t predict which cancers are aggressive and which are ... leads to overtreatment, which can have immediate consequences, such as ...
... cells to ignore premature signals to stop producing important proteins. ... Journal of Experimental Medicine , the findings could lead to ... dystrophy, that are sparked by missing proteins. "When DNA ... than the end of a protein-producing signal, they act like ...
... of Common Human Disease has been chosen as one ... of Health (NIH) grant for Centers of Excellence to ... million over five years. "We,re grateful for ... how epigenetic control affects disease," says the center,s director, ...
Cached Medicine News:Health News:Institute for Aging Research study links high-heels to heel and ankle pain 2Health News:Temps Inc. Acquires Medical Concepts Staffing Business From Analysts International Corporation 2Health News:Men Not Being Told Enough About PSA Tests 2Health News:Men Not Being Told Enough About PSA Tests 3Health News:Men Not Being Told Enough About PSA Tests 4Health News:UCLA study identifies 2 chemicals that could lead to new drugs for genetic disorders 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: